* Applied Molecular Transport Inc. AMTI.OQ AMTI.O is
expected to show no change in quarterly revenue when it reports
results on November 10 (estimated).
* Refinitiv's mean analyst estimate for Applied Molecular
Transport Inc. is for a loss of 62 cents per share. For the same
quarter last year, the company reported a loss of 48 cents per
share.
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for Applied
Molecular Transport Inc. is $74.5, about 67.6% above its last
closing price of $24.12.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Jun. 30 2021 -0.59 -0.60 -0.62 Missed -3.3
Mar. 31 2021 -0.75 -0.75 -0.58 Beat 22.7
Dec. 31 2020 -0.51 -0.47 -0.38 Beat 20
Sep. 30 2020 -0.41 -0.41 -0.48 Missed -17.1
Jun. -0.38 -0.38 -1.11 Missed -192.1
30 2020
This summary was machine generated November 9 at 03:03 GMT. All
figures in US dollars unless otherwise stated